Q1 Pharmacology & Pharmacy Journals

Browse Q1 Pharmacology & Pharmacy journals and compare the highest impact Pharmacology & Pharmacy journals in our database. Each listing includes key details authors often use when choosing where to submit.

Rankings are based on the latest Journal Impact Factor and quartile data currently available in our journal database.

#1
NR
JIF 101.8
Q1
Hybrid

Nature Reviews Drug Discovery is a journal covering drug discovery and development, featuring Reviews, Perspectives, Comments, News in Brief, Research Highlights and related analysis on therapeutics, targets, clinical trials, regulatory science and biopharma t...

Identifiers

ISSN 1474-1776
eISSN 1474-1784

Publication Cost

Subscription publication route only; no immediate gold open access publication option.

Publishing Timeline

Monthly journal.
#2
DR
JIF 21.7
Q1
Hybrid

Drug Resistance Updates publishes original research, commentary, and expert reviews on drug resistance in infectious disease and cancer, as well as novel drugs and strategies to overcome resistance. It covers both basic research and clinical aspects of drug re...

Identifiers

ISSN 1368-7646
eISSN 1532-2084

Publication Cost

USD 5320 APC for open access publication; no open access publication fee for subscription publication.

Publishing Timeline

2 days submission to first decision; 33 days submission to decision after review; 88 days submission to acceptance; 3 days acceptance to online publication
#3
TI
JIF 19.9
Q1
Hybrid

Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that publishes reviews and opinions across pharmacology, pharmacy, pharmaceutics, and toxicology. Launched in 1979, it focuses on recent developments in pharmacology and thera...

Identifiers

ISSN 0165-6147
eISSN 1873-3735

Publication Cost

Subscription-based pricing; prices are displayed in US dollars for consistency, with billing currency varying by region.

Publishing Timeline

1 day submission to first decision; 50 days submission to acceptance
#4
AD
JIF 17.6
Q1
Hybrid

Advanced Drug Delivery Reviews publishes commissioned review articles in Theme Issue format on advanced drug and gene delivery systems and their applications in human and veterinary medicine. The journal covers key issues in effective drug and gene delivery, f...

Identifiers

ISSN 0169-409X
eISSN 1872-8294

Publication Cost

USD 5470 APC for open access; no open access publication fee for subscription articles.

Publishing Timeline

5 days submission to first decision; 51 days submission to decision after review; 116 days submission to acceptance; 3 days acceptance to online publication
#5
PR

American Society for Pharmacology and Experimental Therapeutics

JIF 17.3
Q1
Hybrid

Pharmacological Reviews presents important review articles covering the broad spectrum of pharmacological research, including biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology...

Identifiers

ISSN 0031-6997
eISSN 1521-0081

Publication Cost

Open access APC: USD 4500 for full length articles; USD 3150 for short articles; ASPET members receive a 25% discount. Subscription publication has no open access publication fee.

Publishing Timeline

121 days submission to acceptance
#6
AP
JIF 14.6
Q1
Open

Acta Pharmaceutica Sinica B is a monthly English-language peer-reviewed journal that publishes significant original research articles, rapid communications, and high quality reviews across pharmaceutical sciences, including pharmacology, pharmaceutics, medicin...

Identifiers

ISSN 2211-3835
eISSN 2211-3843

Publication Cost

Article Publishing Charge: USD 2600 for Full Length Articles and Reviews; USD 2000 for Short Articles, excluding taxes.

Publishing Timeline

6 days submission to first decision; 38 days submission to decision after review; 210 days submission to acceptance; 5 days acceptance to online publication
#7
Dr

Adis, Springer Healthcare

JIF 14.4
Q1
Hybrid

Drugs is a journal focused on therapeutics and drug information. For over 50 years it has published reviews and original clinical research on new and established drug therapies across all disease areas to support clinical decision-making through peer-reviewed...

Identifiers

ISSN 0012-6667
eISSN 1179-1950

Publication Cost

Open access APC: £4190.00 GBP / $6290.00 USD / €4990.00 EUR; subscription publishing: no APC charges apply.

Publishing Timeline

Submission to first decision (median): 8 days
#8
AR
JIF 13.1
Q1
Open

Annual Review of Pharmacology and Toxicology covers significant developments in pharmacology and toxicology, including receptors, transporters, enzymes, chemical agents, drug development science, physiological systems such as the immune, central and autonomic...

Identifiers

ISSN 0362-1642
eISSN 1545-4304
#9
P&
JIF 12.5
Q1
Hybrid

Pharmacology & Therapeutics publishes lucid, critical, and authoritative reviews on important topics in pharmacology, including drug actions and the exploitation of drug targets. Disease pathophysiology is covered when it forms part of a narrative around drug...

Identifiers

ISSN 0163-7258
eISSN 1879-016X

Publication Cost

Open access APC: USD 5380 excl. taxes for all articles; subscription publication has no open access publication fee.

Publishing Timeline

9 days submission to first decision; 56 days submission to decision after review; 146 days submission to acceptance; 4 days acceptance to online publication.
#10
AJ
JIF 11.9
Q1
Hybrid

Asian Journal of Pharmaceutical Sciences (AJPS) is the official journal of the Asian Federation for Pharmaceutical Sciences and is indexed by Science Citation Index Expanded. It publishes innovations, production methods, technologies, initiatives, and applicat...

Identifiers

ISSN 1818-0876
eISSN 1818-0876

Publication Cost

No open access publication fee for authors; Shenyang Pharmaceutical University pays the APC.

Publishing Timeline

6 days submission to first decision; 59 days submission to decision after review; 159 days submission to acceptance
#11
MR
JIF 11.6
Q1
Hybrid

Medicinal Research Reviews is a top-ranked medicinal chemistry journal that publishes timely critical reviews and opinion-based articles covering the full range of medicinal research to which authors have made significant contributions.

Identifiers

ISSN 0198-6325
eISSN 1098-1128

Publication Cost

Open access article publication charge (APC) applies and may be covered by an author's institution.

Publishing Timeline

Submission to first decision (median): 23 days; submission to acceptance (median): 251 days; acceptance to publication (median): 18 days.
#12
JO
JIF 11.5
Q1
Hybrid

Journal of Controlled Release is the official journal of the Controlled Release Society and the Japan Society of Drug Delivery System. It publishes high-quality research in delivery science and technology, including drug delivery systems and formulation scienc...

Identifiers

ISSN 0168-3659
eISSN 1873-4995

Publication Cost

USD 4220 APC for open access articles; no open access publication fee for subscription publication.

Publishing Timeline

6 days submission to first decision; 30 days submission to decision after review; 103 days submission to acceptance; 3 days acceptance to online publication
#13
PR
JIF 10.5
Q1
Open

Pharmacological Research is an IUPHAR-affiliated journal that publishes cutting-edge articles in biomedical sciences across molecular, biochemical, translational, and clinical pharmacology, including clinical trials. The journal covers a broad range of topics...

Identifiers

ISSN 1043-6618
eISSN 1096-1186

Publication Cost

Article Publishing Charge: USD 4510 excluding taxes for all articles.

Publishing Timeline

1 day submission to first decision; 31 days submission to decision after review; 73 days submission to acceptance; 2 days acceptance to online publication
#14
JO
JIF 8.9
Q1
Open

Journal of Pharmaceutical Analysis (JPA), launched in 2011, is an official journal of Xi'an Jiaotong University. It is a monthly peer-reviewed open access journal that publishes original research articles, review papers, short communications, news, research hi...

Identifiers

ISSN 2095-1779
eISSN 2214-0883

Publication Cost

Article Publishing Charge: USD 1950 for Full Length Articles and Reviews; USD 975 for Short Communications, excluding taxes.

Publishing Timeline

3 days submission to first decision; 153 days submission to acceptance
#15
AP
JIF 8.4
Q1
Hybrid

Acta Pharmacologica Sinica is a pharmacology journal published on the Nature platform that publishes research articles and review articles and includes both subscription and open access content.

Identifiers

ISSN 1671-4083
eISSN 1745-7254

Publication Cost

£2990.00/$4590.00/€3890.00 APC for open access; no APC under the traditional publishing model.

Publishing Timeline

25 days from submission to the first decision; 30 days from acceptance to online publication
#16
Ph

Elsevier BV

JIF 8.3
Q1
Hybrid

Phytomedicine is the International Journal of Phytotherapy and Phytopharmacology, published in affiliation with the European Scientific Cooperative On Phytotherapy (ESCOP). It is a therapy-oriented journal focused on efficacy, safety, quality, mechanisms of ac...

Identifiers

ISSN 0944-7113
eISSN 1618-095X

Publication Cost

Open Access APC: USD 3,650 (excluding taxes); subscription publication: no publication fee charged to authors

Publishing Timeline

16 days submission to first decision; 43 days submission to decision after review; 125 days submission to acceptance; 2 days acceptance to first online publication
#17
DD

Taylor & Francis

JIF 8.1
Q1
Hybrid

Drug Delivery publishes open access peer-reviewed research on the development and application principles of drug delivery and targeting at molecular, cellular, and higher levels. It covers oral, pulmonary, nasal, parenteral, and transdermal delivery systems, f...

Identifiers

ISSN 1071-7544
eISSN 1521-0464

Publication Cost

Open access publication may be covered through an institutional open access agreement; no journal-specific APC is stated.

Publishing Timeline

From submission to first decision, from submission to first post-review decision, and from acceptance to online publication are reported as average median day metrics.
#18
BJ
British Journal Of Pharmacology

WILEY

JIF 7.7
Q1
Hybrid

Identifiers

ISSN 0007-1188
eISSN 1476-5381
Profile coming soon
#19
AO
JIF 7.5
Q1
Hybrid

Archives of Pharmacal Research is an interdisciplinary journal focusing on original scientific research in drug discovery, development, and actions. It is the official journal of the Pharmaceutical Society of Korea and was first published in 1976.

Identifiers

ISSN 0253-6269
eISSN 1976-3786

Publication Cost

Open access APC: £3390.00 GBP / $5490.00 USD / €4290.00 EUR; subscription publishing: no APC charges apply.

Publishing Timeline

Submission to first decision (median): 11 days
#20
B&
JIF 7.5
Q1
Open

Biomedicine & Pharmacotherapy is a multidisciplinary journal that publishes full-length original research reports, reviews, preliminary communications, and letters to the editor in clinical and basic medicine and pharmacology, including areas such as cancer, n...

Identifiers

ISSN 0753-3322
eISSN 1950-6007

Publication Cost

USD 3610 excluding taxes APC for all articles

Publishing Timeline

2 days submission to first decision; 40 days submission to decision after review; 77 days submission to acceptance; 6 days acceptance to online publication
#21
DD
JIF 7.5
Q1
Hybrid

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The journal covers scientific developments in drug discovery technologies as well as management, commercial, and regulatory issues affecting R&D, including novel the...

Identifiers

ISSN 1359-6446
eISSN 1878-5832

Publication Cost

USD 4480 APC for open access articles; no open access publication fee for subscription articles.

Publishing Timeline

4 days submission to first decision; 38 days submission to decision after review; 90 days submission to acceptance; 5 days acceptance to online publication
#22
CD

Adis, Springer Healthcare

JIF 7.4
Q1
Hybrid

CNS Drugs provides researchers and healthcare professionals with information on drug therapies for the management of neurological and psychiatric disorders. The journal publishes reviews and original research articles addressing pharmacology, efficacy, adverse...

Identifiers

ISSN 1172-7047
eISSN 1179-1934

Publication Cost

£3290.00 GBP / $5290.00 USD / €4190.00 EUR APC for open access; no APC for subscription publishing.

Publishing Timeline

Submission to first decision (median): 10 days
#23
Ne
JIF 7.1
Q1
Hybrid

Neuropsychopharmacology is an official publication of the American College of Neuropsychopharmacology that publishes research and commentary in neuropsychopharmacology.

Identifiers

ISSN 0893-133X
eISSN 1740-634X

Publication Cost

APC: £3590.00/$5290.00/€4190.00; NPP Briefs (Brief Communication) APC: £1750.00/$2575.00/€2040.00; traditional publishing model: no APC charges apply.

Publishing Timeline

Submission to first editorial decision (median days): 2; submission to acceptance (median days): 98.
#24
Bi

Adis, Springer Healthcare

JIF 6.9
Q1
Hybrid

BioDrugs is a hybrid journal covering the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease, serving R&D professionals and clinicians interested in biologic therapies.

Identifiers

ISSN 1173-8804
eISSN 1179-190X

Publication Cost

Open access APC: £3790.00 GBP / $5490.00 USD / €4490.00 EUR; subscription publishing: no APC charges apply.

Publishing Timeline

Submission to first decision (median): 7 days; for original research articles under the rapid publication model, peer review decision within 2 weeks of submission and online publication within 4 weeks of acceptance.
#25
Ne

Springer Science+Business Media

JIF 6.9
Q1
Open

Neurotherapeutics is the official journal of the American Society for Experimental Neurotherapeutics (ASENT). It publishes critical reviews on important topics relating to the treatment of neurological disorders and original research articles in translational...

Identifiers

ISSN 1933-7213
eISSN 1878-7479

Publication Cost

Article Publishing Charge: USD 3900 excluding taxes for all articles; corresponding authors who are members of the American Society for Experimental Neurotherapeutics (ASENT) are eligible for a 30% discount.

Publishing Timeline

2 days submission to first decision; 91 days submission to acceptance
#26
AP

Alimentary Pharmacology & Therapeutics is a global pharmacology journal concerned with the effects of drugs on the human gastrointestinal and hepato-biliary systems, publishing a diverse range of topics often with immediate clinical impact. It is interested in...

Identifiers

ISSN 0269-2813
eISSN 1365-2036

Publication Cost

FREE submission; authors can choose to publish open access after full peer-review

Publishing Timeline

2 days submission to first decision (median); 11 days submission to first decision on average in 2024 excluding Letters, Editorials and Replies; 7 weeks from acceptance to publication in an online issue; final corrected proofs published 16-24 days after acceptance
#27
EN
JIF 6.7
Q1
Hybrid

European Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology and focuses on clinical and basic science contributions that advance understanding of brain function and human behaviour, with emphasis on translating n...

Identifiers

ISSN 0924-977X
eISSN 1873-7862

Publication Cost

Article Publishing Charge: USD 3000 excl. taxes for all articles published open access; no open access publication fee for subscription articles.

Publishing Timeline

45 days submission to decision after review; 33 days submission to acceptance
#28
IJ
International Journal Of Nanomedicine

Dove Medical Press

JIF 6.5
Q1
Open

An international, peer-reviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. The aim of the journal is to highlight research and development leading to potential...

Identifiers

ISSN 1178-2013
eISSN 1178-2013

Publication Cost

US$3940.00 / £2920.00 / €3505.00 APC after acceptance; UK invoices subject to 20% VAT.

Publishing Timeline

47 days average from submission to first editorial decision; 13 days average from editorial acceptance to publication
Profile coming soon
#29
IJ
International Journal Of Pharmaceutics-x

Elsevier BV

JIF 6.4
Q1
Open

International Journal of Pharmaceutics: X is a gold open access journal for pharmaceutical scientists focused on the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manuf...

Identifiers

eISSN 2590-1567

Publication Cost

Article Publishing Charge: USD 2850 for Full Length Articles and Reviews; USD 2270 for Mini Reviews, excluding taxes.

Publishing Timeline

2 days submission to first decision; 29 days submission to decision after review; 82 days submission to acceptance; 2 days acceptance to online publication
Profile coming soon
#30
PR
JIF 6.3
Q1
Hybrid

Phytotherapy Research is an international pharmacological journal publishing original medicinal plant research for biochemists, pharmacologists, and toxicologists. Its key areas of interest include pharmacology, toxicology, and the clinical applications of her...

Identifiers

ISSN 0951-418X
eISSN 1099-1573

Publication Cost

Open access article publication charge (APC) applies; coverage may be available through an author's institution or funder.

Publishing Timeline

Median submission to first decision: 18 days; median submission to acceptance: 179 days; median acceptance to publication: 37 days.
#31
EH
JIF 6.1
Q1
Open

European Heart Journal – Cardiovascular Pharmacotherapy is an ESC Publications journal focused on cardiovascular medicine and pharmacology. It became fully Open Access from January 2025, with all accepted submissions from 3 September 2024 publishing under an O...

Identifiers

ISSN 2055-6837
eISSN 2055-6845

Publication Cost

An Article Processing Charge may be payable for accepted submissions publishing in the 2025 volume; the journal has no submission fees, offers a 20% APC discount for eligible ESC members, and partial or full waivers may be available for corresponding authors in eligible LMIC countries.

Publishing Timeline

First decision within an average of 9 days; accepted manuscripts published on Advance Access within 2 days of receipt at OUP if the licence is signed promptly.
#32
CM

BioMed Central

JIF 5.7
Q1
Open

Chinese Medicine is an open access journal publishing evidence-based, scientifically justified research and review papers in all aspects of Chinese medicine, including chemistry, biology, pharmacology, pharmaceutics, engineering, clinical applications and soci...

Identifiers

ISSN 1749-8546
eISSN 1749-8546

Publication Cost

APC: £2290.00 GBP / $3090.00 USD / €2590.00 EUR; VAT or local taxes may apply.

Publishing Timeline

Submission to first decision (median): 8 days
#33
BP
JIF 5.6
Q1
Hybrid

Biochemical Pharmacology publishes original research findings and review articles on cellular and tissue functions at the biochemical and molecular levels, drug- and genetic-induced modification of cellular phenotypes, and the pharmacodynamics and pharmacokine...

Identifiers

ISSN 0006-2952
eISSN 1873-2968

Publication Cost

USD 3420 APC for open access; no open access publication fee for subscription publication.

Publishing Timeline

12 days submission to first decision; 46 days submission to decision after review; 106 days submission to acceptance; 2 days acceptance to online publication
#34
CP
Clinical Pharmacology & Therapeutics

WILEY

JIF 5.5
Q1

Identifiers

ISSN 0009-9236
eISSN 1532-6535
Profile coming soon
#35
DD

Springer Science+Business Media

JIF 5.5
Q1
Hybrid

Drug Delivery and Translational Research is an official journal of the Controlled Release Society and a dedicated platform for high-quality research focused on translational aspects of drug delivery and novel drug delivery systems. It explores rationally devel...

Identifiers

ISSN 2190-393X
eISSN 2190-3948

Publication Cost

Open access APC: £3190.00 GBP / $4890.00 USD / €3990.00 EUR; subscription publishing: no APC charges apply.

Publishing Timeline

Submission to first decision (median): 12 days
#36
JO
Journal Of Psychopharmacology

SAGE Publishing

JIF 5.5
Q1
Hybrid

The Journal of Psychopharmacology is a fully peer-reviewed international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology and serves researchers and practicing clinicians.

Identifiers

ISSN 0269-8811
eISSN 1461-7285

Publication Cost

APC varies by journal title under Sage Choice pricing.

Publishing Timeline

Median time to first decision: 20 days; median time in peer review: 53 days; median time from submission to acceptance: 145 days; median time from acceptance to online publication: 50 days.
Profile coming soon
#37
Ph
Pharmaceutics

MDPI

JIF 5.5
Q1

Identifiers

eISSN 1999-4923
Profile coming soon
#38
CI
Chemico-biological Interactions

ELSEVIER IRELAND LTD

JIF 5.4
Q1

Identifiers

ISSN 0009-2797
eISSN 1872-7786
Profile coming soon
#39
EO
Expert Opinion On Drug Delivery

TAYLOR & FRANCIS LTD

JIF 5.4
Q1

Identifiers

ISSN 1742-5247
eISSN 1744-7593
Profile coming soon
#40
JO
JIF 5.4
Q1
Hybrid

Journal of Ethnopharmacology is the official journal of the International Society for Ethnopharmacology and focuses on the use of plants, fungi, animals, microorganisms, and minerals in traditional medicine and their biological and pharmacological effects. It...

Identifiers

ISSN 0378-8741
eISSN 1872-7573

Publication Cost

Open access APC: USD 3,580 excluding taxes; subscription publication fee: no publication fee charged to authors.

Publishing Timeline

4 days to first decision; 43 days to decision after review; 85 days to acceptance; 2 days from acceptance to first online publication.
#41
MD
Marine Drugs

MDPI

JIF 5.4
Q1

Identifiers

eISSN 1660-3397
Profile coming soon
#42
CN
Current Neuropharmacology

BENTHAM SCIENCE PUBL LTD

JIF 5.3
Q1

Identifiers

ISSN 1570-159X
eISSN 1875-6190
Profile coming soon
#43
IJ
International Journal Of Pharmaceutics

ELSEVIER

JIF 5.2
Q1

Identifiers

ISSN 0378-5173
eISSN 1873-3476
Profile coming soon
#44
DD
Drug Design Development And Therapy

DOVE MEDICAL PRESS LTD

JIF 5.1
Q1

Identifiers

ISSN 1177-8881
Profile coming soon
#45
JO
Journal Of Pharmaceutical Investigation

SPRINGERNATURE

JIF 5.1
Q1

Identifiers

ISSN 2093-5552
eISSN 2093-6214
Profile coming soon
#46
LS
Life Sciences

PERGAMON-ELSEVIER SCIENCE LTD

JIF 5.1
Q1

Identifiers

ISSN 0024-3205
eISSN 1879-0631
Profile coming soon
#47
CN
Cns Neuroscience & Therapeutics

WILEY

JIF 5
Q1

Identifiers

ISSN 1755-5930
eISSN 1755-5949
Profile coming soon
#48
CJ
JIF 4.9
Q1
Open

Chinese Journal of Natural Medicines (CJNM), founded and sponsored in May 2003 by China Pharmaceutical University and the Chinese Pharmaceutical Association, focuses on advancing Traditional Chinese Medicines through research on bioactive natural products, lea...

Identifiers

ISSN 2095-6975
eISSN 1875-5364

Publication Cost

Article publishing charge (APC) applies for open access articles if the manuscript is accepted.

Publishing Timeline

1 day submission to first decision; 417 days from submission to acceptance for accepted papers (median)
#49
EO
Expert Opinion On Drug Discovery

TAYLOR & FRANCIS LTD

JIF 4.9
Q1

Identifiers

ISSN 1746-0441
eISSN 1746-045X
Profile coming soon
#50
JO
Journal Of Drug Delivery Science And Technology

ELSEVIER

JIF 4.9
Q1

Identifiers

ISSN 1773-2247
eISSN 2588-8943
Profile coming soon
#51
FI
Frontiers In Pharmacology

FRONTIERS MEDIA SA

JIF 4.8
Q1

Identifiers

eISSN 1663-9812
Profile coming soon
#52
PB

Taylor & Francis

JIF 4.8
Q1
Open

Pharmaceutical Biology is a peer-reviewed, open access journal publishing research on natural medicines and drugs, biologically active natural products or their derivatives, and complex traditional medicine formulas. It covers natural product research related...

Identifiers

ISSN 1388-0209
eISSN 1744-5116

Publication Cost

An Article Publishing Charge (APC) may apply for open access publication; reduced APCs, waivers, or no-cost publication may be available through institutional or funder agreements.

Publishing Timeline

From submission to first decision, from submission to first post-review decision, and from acceptance to online publication are reported as average (median) day-based metrics, but no values are given.
#53
Ph
Pharmaceuticals

MDPI

JIF 4.8
Q1

Identifiers

eISSN 1424-8247
Profile coming soon
#54
EJ
European Journal Of Pharmaceutical Sciences

ELSEVIER

JIF 4.7
Q1

Identifiers

ISSN 0928-0987
eISSN 1879-0720
Profile coming soon
#55
EJ
European Journal Of Pharmacology

ELSEVIER

JIF 4.7
Q1

Identifiers

ISSN 0014-2999
eISSN 1879-0712
Profile coming soon
#56
An

Multidisciplinary Digital Publishing Institute

JIF 4.6
Q1
Open

Antibiotics is an international, peer-reviewed, open access journal on all aspects of antibiotics, published monthly online by MDPI. It is indexed in PubMed and has a JCR Q1 quartile ranking in Infectious Diseases and Pharmacology and Pharmacy.

Identifiers

ISSN 2079-6382
eISSN 2079-6382

Publication Cost

Article processing charges apply; Croatian Pharmacological Society members receive discounts.

Publishing Timeline

Time to first decision: 17 days
#57
EO
Expert Opinion On Therapeutic Patents

TAYLOR & FRANCIS LTD

JIF 4.6
Q1

Identifiers

ISSN 1354-3776
eISSN 1744-7674
Profile coming soon
#58
IJ

The International Journal of Antimicrobial Agents is the official journal of the International Society of Antimicrobial Chemotherapy and publishes peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of antimic...

Identifiers

ISSN 0924-8579
eISSN 1872-7913

Publication Cost

Open access APC: USD 3,280 excluding taxes. Subscription publication has no publication fee charged to authors.

Publishing Timeline

10 days to first decision; 64 days to decision after review; 144 days to acceptance; 6 days from acceptance to online publication
#59
JO
Journal Of Clinical Lipidology

ELSEVIER SCIENCE INC

JIF 4.6
Q1

Identifiers

ISSN 1933-2874
eISSN 1876-4789
Profile coming soon
#60
Ne
Neuropharmacology

PERGAMON-ELSEVIER SCIENCE LTD

JIF 4.6
Q1

Identifiers

ISSN 0028-3908
eISSN 1873-7064
Profile coming soon
#61
Ph

Adis, Springer Healthcare

JIF 4.6
Q1
Hybrid

PharmacoEconomics is a peer-reviewed journal focused on the practical application of health economics and outcomes research to optimize healthcare resource allocation. It emphasizes clear communication of complex pharmacoeconomic issues across healthcare inter...

Identifiers

ISSN 1170-7690
eISSN 1179-2027

Publication Cost

Traditional subscription-based publication does not charge authors; open access publication is available as an option for accepted articles.

Publishing Timeline

Submission to first decision (median): 7 days
#62
To
Toxicology

ELSEVIER IRELAND LTD

JIF 4.6
Q1

Identifiers

ISSN 0300-483X
eISSN 1879-3185
Profile coming soon
#63
AA
Antimicrobial Agents And Chemotherapy

AMER SOC MICROBIOLOGY

JIF 4.5
Q1

Identifiers

ISSN 0066-4804
eISSN 1098-6596
Profile coming soon
#64
PM
Pharmaceutical Medicine

SPRINGER INT PUBL AG

JIF 4.5
Q1

Identifiers

ISSN 1178-2595
eISSN 1179-1993
Profile coming soon
#65
EO
Expert Opinion On Therapeutic Targets

TAYLOR & FRANCIS LTD

JIF 4.4
Q1

Identifiers

ISSN 1472-8222
eISSN 1744-7631
Profile coming soon
#66
MD

Adis, Springer Healthcare

JIF 4.4
Q1
Hybrid

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine. The journal publishes reviews and original research articles focu...

Identifiers

ISSN 1177-1062
eISSN 1179-2000

Publication Cost

No charge for the traditional subscription-based publishing route; open access publication is available as an option for accepted articles.

Publishing Timeline

Submission to first decision (median): 7 days
#67
AA
Admet And Dmpk

IAPC PUBLISHING

JIF 4.3
Q1

Identifiers

ISSN 1848-7718
eISSN 1848-7718
Profile coming soon
#68
EJ
European Journal Of Pharmaceutics And Biopharmaceutics

ELSEVIER

JIF 4.3
Q1

Identifiers

ISSN 0939-6411
eISSN 1873-3441
Profile coming soon
#69
JO
Journal Of Cannabis Research

BMC

JIF 4.3
Q1

Identifiers

eISSN 2522-5782
Profile coming soon
#70
JO
Journal Of Liposome Research

TAYLOR & FRANCIS LTD

JIF 4.3
Q1

Identifiers

ISSN 0898-2104
eISSN 1532-2394
Profile coming soon
#71
JO
Journal Of Pharmacy And Pharmaceutical Sciences

FRONTIERS MEDIA SA

JIF 4.3
Q1

Identifiers

eISSN 1482-1826
Profile coming soon
#72
PR
Pharmaceutical Research

SPRINGER/PLENUM PUBLISHERS

JIF 4.3
Q1

Identifiers

ISSN 0724-8741
eISSN 1573-904X
Profile coming soon
#73
AP
Australian Prescriber

Therapeutic Guidelines Ltd

JIF 4.2
Q1

Identifiers

ISSN 0312-8008
eISSN 1839-3942
Profile coming soon
#74
CO
Current Opinion In Pharmacology

ELSEVIER SCI LTD

JIF 4.2
Q1

Identifiers

ISSN 1471-4892
eISSN 1471-4973
Profile coming soon
#75
DD
Drug Development Research

WILEY

JIF 4.2
Q1

Identifiers

ISSN 0272-4391
eISSN 1098-2299
Profile coming soon
#76
ET
Environmental Toxicology And Pharmacology

ELSEVIER

JIF 4.2
Q1

Identifiers

ISSN 1382-6689
eISSN 1872-7077
Profile coming soon
#77
AP
Advanced Pharmaceutical Bulletin

TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES

JIF 4.1
Q1

Identifiers

ISSN 2228-5881
eISSN 2251-7308
Profile coming soon
#78
EO
Expert Opinion On Investigational Drugs

TAYLOR & FRANCIS LTD

JIF 4.1
Q1

Identifiers

ISSN 1354-3784
eISSN 1744-7658
Profile coming soon
#79
AP
Aaps Pharmscitech

SPRINGER

JIF 4
Q1

Identifiers

ISSN 1530-9932
eISSN 1530-9932
Profile coming soon
#80
AR
Antiviral Research

ELSEVIER

JIF 4
Q1

Identifiers

ISSN 0166-3542
eISSN 1872-9096
Profile coming soon
#81
CP
Clinical Pharmacokinetics

ADIS INT LTD

JIF 4
Q1

Identifiers

ISSN 0312-5963
eISSN 1179-1926
Profile coming soon
#82
DM
Drug Metabolism And Disposition

ELSEVIER SCIENCE INC

JIF 4
Q1

Identifiers

ISSN 0090-9556
eISSN 1521-009X
Profile coming soon
#83
TA
Therapeutic Advances In Psychopharmacology

SAGE PUBLICATIONS LTD

JIF 4
Q1

Identifiers

ISSN 2045-1253
eISSN 2045-1261
Profile coming soon
#84
JO
Journal Of Drug Targeting

TAYLOR & FRANCIS LTD

JIF 3.9
Q1

Identifiers

ISSN 1061-186X
eISSN 1029-2330
Profile coming soon
#85
PI
Progress In Neuro-psychopharmacology & Biological Psychiatry

PERGAMON-ELSEVIER SCIENCE LTD

JIF 3.9
Q1

Identifiers

ISSN 0278-5846
eISSN 1878-4216
Profile coming soon
#86
ER
JIF 3.8
Q1
Hybrid

Expert Review of Anti-infective Therapy is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on therapeutics and diagnostics in the treatment of infectious disease. Articles inco...

Identifiers

ISSN 1478-7210
eISSN 1744-8336

Publication Cost

Authors can publish gold open access in this journal.

Publishing Timeline

Accelerated publication is offered.
#87
IJ
International Journal Of Neuropsychopharmacology

OXFORD UNIV PRESS

JIF 3.7
Q1

Identifiers

ISSN 1461-1457
eISSN 1469-5111
Profile coming soon
#88
RT
Regulatory Toxicology And Pharmacology

ACADEMIC PRESS INC ELSEVIER SCIENCE

JIF 3.5
Q1

Identifiers

ISSN 0273-2300
eISSN 1096-0295
Profile coming soon
#89
PD
Pediatric Drugs

ADIS INT LTD

JIF 3.3
Q1

Identifiers

ISSN 1174-5878
eISSN 1179-2019
Profile coming soon
#90
SP
Skin Pharmacology And Physiology

KARGER

JIF 3.2
Q1

Identifiers

ISSN 1660-5527
eISSN 1660-5535
Profile coming soon
Preparing a manuscript for a high-impact journal?

Livewrite works inside Microsoft Word to help researchers write, edit, cite, review, and format manuscripts for journal submission.